Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

Ninth European International Kidney Cancer Symposium

25 - 26 Apr 2014
Dublin, Dublin, Ireland
Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the real...
Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA
Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the real world: Introduction ( Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA )
23 Sep 2014
Additional treatment options impact first-line treatment of mRCC: No
Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, Paris, France
Additional treatment options impact first-line treatment of mRCC: No ( Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, Paris, France )
23 Sep 2014
Current treatment options in mRCC
Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA
Current treatment options in mRCC ( Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA )
23 Sep 2014
Discussion: Additional treatment options impact first-line treatment of mRCC
Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán
Discussion: Additional treatment options impact first-line treatment of mRCC ( Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán )
23 Sep 2014
Additional treatment options impact first-line treatment of mRCC: Yes
Prof Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium
Additional treatment options impact first-line treatment of mRCC: Yes ( Prof Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )
23 Sep 2014
What have we learned? Expert perspectives
Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán
What have we learned? Expert perspectives ( Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán )
23 Sep 2014
From clinical trial to clinical practice: Evidence from the real world
Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid, Madr...
From clinical trial to clinical practice: Evidence from the real world ( Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid, Madrid, Spain )
23 Sep 2014
Gene targeting in kidney cancer treatment
Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
Gene targeting in kidney cancer treatment ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
6 May 2014
Surgical strategies available for renal cell carcinoma with inferior vena cava i...
Prof Christopher G. Wood - The University of Texas MD Anderson Cancer Center, Ho...
Surgical strategies available for renal cell carcinoma with inferior vena cava invasion ( Prof Christopher G. Wood - The University of Texas MD Anderson Cancer Center, Houston, USA )
6 May 2014
Use of robotics in kidney cancer surgery
Dr Christophe Vaessen - Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Use of robotics in kidney cancer surgery ( Dr Christophe Vaessen - Groupe Hospitalier Pitié-Salpêtrière, Paris, France )
6 May 2014
Work and history of the Kidney Cancer Association
Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer A...
Work and history of the Kidney Cancer Association ( Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer Association, Chicago, USA )
6 May 2014
Intratumour heterogeneity in renal and lung cancer
Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK
Intratumour heterogeneity in renal and lung cancer ( Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK )
6 May 2014
Kidney cancer treatment ten years from now
Prof Martin Gore - The Royal Marsden Hospital, London, UK
Kidney cancer treatment ten years from now ( Prof Martin Gore - The Royal Marsden Hospital, London, UK )
6 May 2014